Medication Therapy Management Return on Investment
Real Time Impact of Medication Management
Total Drug Therapy
Problems Resolved
Overall Healthcare
$ SAVED
Total healthcare cost savings are based on reductions in the cost of medications as well as expected avoidance of adverse drug events and secondary health complications that result from medication misuse.
The savings represent an estimated cost savings based on a critical review of published medical studies.
The real time $ savings ticker is based on SinfoníaRx's 8-year program experience.
This estimate is adjusted quarterly.
MEDICARE - Current Year Through 9/30/2018
Total Patients 9,108,894
Total MTM Qualified Patients 1,044,851
Total Patients with Interventions 703,587
COMMERCIAL - Current Year Through 9/30/2018
Total Patients 1,787,847
Total MTM Qualified Patients 126,276
Total Patients with Interventions 53,670
TOP TEN DRUG THERAPY PROBLEMS RESOLVED
- High-Risk Medication - Anticholinergic
- High-Risk Medication – Non-Benzodiazepine Hypnotic
- High-Risk Medication – Muscle Relaxant
- Medication Adherence - Statin Medication
- Medication Adherence – Renin Angiotensin System Antagonist
- High-Risk Medication - Benzodiazepine
- High-Risk Medication - Hypoglycemic
- Medication Adherence – Diabetes Medication
- Drug to Drug Interaction - NSAID and Warfarin
- Drug to Drug Interaction - Warfarin and Bactrim
SinfoníaRx | Tucson | Compliance Reporting
Corporate Office: 100 N. Stone Ave., Suite 109 | Tucson, AZ 85701 | (520) 499-3388 | info@sinfoniarx.com
Patient services are provided without regard to race, color, religion, gender, sexual orientation, disability
(mental or physical), communicable diseases or place of national origin.
Content on this website includes words and photos originally produced by the University of Arizona
College of Pharmacy. Used by permission.